Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer—a multicentre, open, controlled, prospectively randomised trial

Autor:	von Minckwitz, G., Loibl, S., Brunnert, K., Kreienberg, R., Melchert, F., Mösch, R., Neises, M., Schermann, J., Seufert, R., Stiglmayer, R., Stosiek, U., Kaufmann, M.
Zdroj:	In European Journal of Cancer November 2002 38(17):2265-2271
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect